Status:
TERMINATED
Valsartan in Cardiovascular Disease With Renal Dysfunction (The V-CARD) Study
Lead Sponsor:
Kumamoto University
Conditions:
Hypertension
Eligibility:
All Genders
30-85 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to investigate if an angiotensin II receptor blocker, valsartan 160 mg/day is more effective to reduce the incidence of cardiovascular events as compared to 40 mg/day in p...
Detailed Description
It is well known that patients with renal dysfunction have a poor prognosis concerning cardiovascular diseases. That is called "cardiorenal syndrome". It was reported that valsartan was effective in r...
Eligibility Criteria
Inclusion
- Inclusion Criteria (all required):
- Systolic blood pressure (SBP) \>/= 140 and/or diastolic blood pressure (DBP) \>/= 90 (untreated hypertension cases); or SBP\>/=130 and/or DBP\>/=80 (treated hypertension cases)
- Patients with coronary artery disease (more than 50% stenosis on coronary angiography \[CAG\], coronary computed tomography \[CT\] or coronary magnetic resonance angiography \[MRA\]; coronary spasm; or history of percutaneous coronary intervention \[PCI\]);Unstable angina patient
- Creatinine clearance between 30.0 and 89.9 ml/min
- Exclusion Criteria (at least one of following):
- Reduced left ventricular (LV) function (ejection fraction \[EF\] equal to or less than 40%)
- Hyperpotassemia (serum potassium equal to or more than 5.5 mEq/l)
- Rapid progressive glomerular nephritis
- Nephrotic syndrome
- Renal artery stenosis
- Uncontrolled diabetes (HbA1c equal to or more than 9.0%)
- History of allergy to valsartan
- Pregnant women
Exclusion
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00140790
Start Date
August 1 2006
End Date
March 1 2015
Last Update
February 26 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Cardiovascular Medicine, Kumamoto University Hospital
Kumamoto, Kumamoto, Japan, 860-8556
2
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University
Kumamoto, Japan, 860-8556